W. Middlekauff
Net worth: 253 250 $ as of 31/05/2026
Net worth: 253 250 $ as of 31/05/2026
W.
Bradford Middlekauff is currently an Independent Director at Amanat Acquisition Corp.
since 2026 and Chief Business Officer & General Counsel at Tourmaline Sub, Inc. since 2022.
Former positions include Chairman at Biotechnology Innovation Organization, Director at SpliceBio SL, Senior Vice President-Strategic Planning at Medarex, Inc. from 2000 to 2008, VP-Business Development & General Counsel at Algos Pharmaceutical Corp.
from 1998 to 2000, Secretary, Chief Legal Officer & General Counsel at Kolltan Pharmaceuticals, Inc. from 2008 to 2013, Secretary, Senior Vice President & General Counsel at Edge Therapeutics, Inc., Associate at Cooley Godward LLP from 1993 to 1998, Secretary & Chief Legal Officer at PDS Biotechnology Corp.
in 2019, General Counsel at Immunovant, Inc. from 2019 to 2020, Chief Legal Officer at Castle Creek Biosciences, Inc. from 2021 to 2022, and Secretary & Chief Business Officer at Tourmaline Bio, Inc. from 2023 to 2025.
Education includes undergraduate studies at Brown University and graduate studies at Yale Law School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.15% | 20/05/2026 | 25,000 ( 1.15% ) | 253 250 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | General Counsel | 01/06/2022 |
| Companies | Position | End |
|---|---|---|
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | General Counsel | 01/05/2022 |
| IMMUNOVANT, INC. | General Counsel | 01/11/2020 |
| PDS BIOTECHNOLOGY CORPORATION | General Counsel | 12/04/2019 |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | General Counsel | 01/08/2013 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Algos Pharmaceutical Corp.
Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and makes pain management products including narcotic drugs | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley Godward LLP
Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Yale Law School
Yale Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
PDS Biotechnology Corp.
PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions